Home > > > > > Report Detail

Global Amifostine Market Growth 2020-2025

Publisher Name :
Date: 18-Feb-2020
No. of pages: 138

According to this study, over the next five years the Amifostine market will register a 2.3% CAGR in terms of revenue, the global market size will reach $ 54 million by 2025, from $ 49 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Amifostine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by type, application, key manufacturers and key regions and countries.

This study considers the Amifostine value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- 400mg/Dose

- 500mg/Dose

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Head and Neck Cancer Adjuvant Therapy

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Clinigen

- Sun Pharmaceutical

- Merro Pharmaceutical

- Luye Pharma

- Taj Pharmaceuticals

- Mingren Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Amifostine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Amifostine market by identifying its various subsegments.

- Focuses on the key global Amifostine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Amifostine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Amifostine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Amifostine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amifostine Consumption 2015-2025
2.1.2 Amifostine Consumption CAGR by Region
2.2 Amifostine Segment by Type
2.2.1 400mg/Dose
2.2.2 500mg/Dose
2.3 Amifostine Consumption by Type
2.3.1 Global Amifostine Consumption Market Share by Type (2015-2020)
2.3.2 Global Amifostine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Amifostine Sale Price by Type (2015-2020)
2.4 Amifostine Segment by Application
2.4.1 Head and Neck Cancer Adjuvant Therapy
2.4.2 Others
2.5 Amifostine Consumption by Application
2.5.1 Global Amifostine Consumption Market Share by Type (2015-2020)
2.5.2 Global Amifostine Value and Market Share by Type (2015-2020)
2.5.3 Global Amifostine Sale Price by Type (2015-2020)

3 Global Amifostine by Company
3.1 Global Amifostine Sales Market Share by Company
3.1.1 Global Amifostine Sales by Company (2018-2020)
3.1.2 Global Amifostine Sales Market Share by Company (2018-2020)
3.2 Global Amifostine Revenue Market Share by Company
3.2.1 Global Amifostine Revenue by Company (2018-2020)
3.2.2 Global Amifostine Revenue Market Share by Company (2018-2020)
3.3 Global Amifostine Sale Price by Company
3.4 Global Amifostine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Amifostine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Amifostine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Amifostine by Regions
4.1 Amifostine by Regions
4.2 Americas Amifostine Consumption Growth
4.3 APAC Amifostine Consumption Growth
4.4 Europe Amifostine Consumption Growth
4.5 Middle East & Africa Amifostine Consumption Growth

5 Americas
5.1 Americas Amifostine Consumption by Countries
5.1.1 Americas Amifostine Consumption by Countries (2015-2020)
5.1.2 Americas Amifostine Value by Countries (2015-2020)
5.2 Americas Amifostine Consumption by Type
5.3 Americas Amifostine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Amifostine Consumption by Regions
6.1.1 APAC Amifostine Consumption by Regions (2015-2020)
6.1.2 APAC Amifostine Value by Regions (2015-2020)
6.2 APAC Amifostine Consumption by Type
6.3 APAC Amifostine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Amifostine by Countries
7.1.1 Europe Amifostine Consumption by Countries (2015-2020)
7.1.2 Europe Amifostine Value by Countries (2015-2020)
7.2 Europe Amifostine Consumption by Type
7.3 Europe Amifostine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Amifostine by Countries
8.1.1 Middle East & Africa Amifostine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Amifostine Value by Countries (2015-2020)
8.2 Middle East & Africa Amifostine Consumption by Type
8.3 Middle East & Africa Amifostine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Amifostine Distributors
10.3 Amifostine Customer

11 Global Amifostine Market Forecast
11.1 Global Amifostine Consumption Forecast (2021-2025)
11.2 Global Amifostine Forecast by Regions
11.2.1 Global Amifostine Forecast by Regions (2021-2025)
11.2.2 Global Amifostine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Amifostine Forecast by Type
11.8 Global Amifostine Forecast by Application

12 Key Players Analysis
12.1 Clinigen
12.1.1 Company Information
12.1.2 Amifostine Product Offered
12.1.3 Clinigen Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Clinigen Latest Developments
12.2 Sun Pharmaceutical
12.2.1 Company Information
12.2.2 Amifostine Product Offered
12.2.3 Sun Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sun Pharmaceutical Latest Developments
12.3 Merro Pharmaceutical
12.3.1 Company Information
12.3.2 Amifostine Product Offered
12.3.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merro Pharmaceutical Latest Developments
12.4 Luye Pharma
12.4.1 Company Information
12.4.2 Amifostine Product Offered
12.4.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Luye Pharma Latest Developments
12.5 Taj Pharmaceuticals
12.5.1 Company Information
12.5.2 Amifostine Product Offered
12.5.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Taj Pharmaceuticals Latest Developments
12.6 Mingren Pharma
12.6.1 Company Information
12.6.2 Amifostine Product Offered
12.6.3 Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mingren Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Amifostine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 400mg/Dose
Table 5. Major Players of 500mg/Dose
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Amifostine Consumption Market Share by Type (2015-2020)
Table 8. Global Amifostine Revenue by Type (2015-2020) ($ million)
Table 9. Global Amifostine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Amifostine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Amifostine Consumption Market Share by Application (2015-2020)
Table 13. Global Amifostine Value by Application (2015-2020)
Table 14. Global Amifostine Value Market Share by Application (2015-2020)
Table 15. Global Amifostine Sale Price by Application (2015-2020)
Table 16. Global Amifostine Sales by Company (2017-2019) (MT)
Table 17. Global Amifostine Sales Market Share by Company (2017-2019)
Table 18. Global Amifostine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Amifostine Revenue Market Share by Company (2017-2019)
Table 20. Global Amifostine Sale Price by Company (2017-2019)
Table 21. Global Amifostine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Amifostine Products Offered
Table 23. Amifostine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Amifostine Consumption by Regions 2015-2020 (MT)
Table 25. Global Amifostine Consumption Market Share by Regions 2015-2020
Table 26. Global Amifostine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Amifostine Value Market Share by Regions 2015-2020
Table 28. Americas Amifostine Consumption by Countries (2015-2020) (MT)
Table 29. Americas Amifostine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Amifostine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Amifostine Value Market Share by Countries (2015-2020)
Table 32. Americas Amifostine Consumption by Type (2015-2020) (MT)
Table 33. Americas Amifostine Consumption Market Share by Type (2015-2020)
Table 34. Americas Amifostine Consumption by Application (2015-2020) (MT)
Table 35. Americas Amifostine Consumption Market Share by Application (2015-2020)
Table 36. APAC Amifostine Consumption by Countries (2015-2020) (MT)
Table 37. APAC Amifostine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Amifostine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Amifostine Value Market Share by Regions (2015-2020)
Table 40. APAC Amifostine Consumption by Type (2015-2020) (MT)
Table 41. APAC Amifostine Consumption Market Share by Type (2015-2020)
Table 42. APAC Amifostine Consumption by Application (2015-2020) (MT)
Table 43. APAC Amifostine Consumption Market Share by Application (2015-2020)
Table 44. Europe Amifostine Consumption by Countries (2015-2020) (MT)
Table 45. Europe Amifostine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Amifostine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Amifostine Value Market Share by Countries (2015-2020)
Table 48. Europe Amifostine Consumption by Type (2015-2020) (MT)
Table 49. Europe Amifostine Consumption Market Share by Type (2015-2020)
Table 50. Europe Amifostine Consumption by Application (2015-2020) (MT)
Table 51. Europe Amifostine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Amifostine Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Amifostine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Amifostine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Amifostine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Amifostine Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Amifostine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Amifostine Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Amifostine Consumption Market Share by Application (2015-2020)
Table 60. Amifostine Distributors List
Table 61. Amifostine Customer List
Table 62. Global Amifostine Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Amifostine Consumption Market Forecast by Regions
Table 64. Global Amifostine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Amifostine Value Market Share Forecast by Regions
Table 66. Global Amifostine Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Amifostine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Amifostine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Amifostine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Amifostine Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Amifostine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Amifostine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Amifostine Value Market Share Forecast by Application (2021-2025)
Table 74. Clinigen Product Offered
Table 75. Clinigen Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Clinigen Main Business
Table 77. Clinigen Latest Developments
Table 78. Clinigen Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sun Pharmaceutical Product Offered
Table 80. Sun Pharmaceutical Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Sun Pharmaceutical Main Business
Table 82. Sun Pharmaceutical Latest Developments
Table 83. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merro Pharmaceutical Product Offered
Table 85. Merro Pharmaceutical Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Merro Pharmaceutical Main Business
Table 87. Merro Pharmaceutical Latest Developments
Table 88. Merro Pharmaceutical Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 89. Luye Pharma Product Offered
Table 90. Luye Pharma Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Luye Pharma Main Business
Table 92. Luye Pharma Latest Developments
Table 93. Luye Pharma Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 94. Taj Pharmaceuticals Product Offered
Table 95. Taj Pharmaceuticals Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Taj Pharmaceuticals Main Business
Table 97. Taj Pharmaceuticals Latest Developments
Table 98. Taj Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 99. Mingren Pharma Product Offered
Table 100. Mingren Pharma Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Mingren Pharma Main Business
Table 102. Mingren Pharma Latest Developments
Table 103. Mingren Pharma Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Amifostine
Figure 2. Amifostine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Amifostine Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Amifostine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 400mg/Dose
Figure 7. Product Picture of 500mg/Dose
Figure 8. Global Amifostine Consumption Market Share by Type (2015-2020)
Figure 9. Global Amifostine Value Market Share by Type (2015-2020)
Figure 10. Amifostine Consumed in Head and Neck Cancer Adjuvant Therapy
Figure 11. Global Amifostine Market: Head and Neck Cancer Adjuvant Therapy (2015-2020) (MT)
Figure 12. Global Amifostine Market: Head and Neck Cancer Adjuvant Therapy (2015-2020) ($ Millions)
Figure 13. Amifostine Consumed in Others
Figure 14. Global Amifostine Market: Others (2015-2020) (MT)
Figure 15. Global Amifostine Market: Others (2015-2020) ($ Millions)
Figure 16. Global Amifostine Consumption Market Share by Application (2015-2020)
Figure 17. Global Amifostine Value Market Share by Application (2015-2020)
Figure 18. Global Amifostine Sales Market Share by Company in 2017
Figure 19. Global Amifostine Sales Market Share by Company in 2019
Figure 20. Global Amifostine Revenue Market Share by Company in 2017
Figure 21. Global Amifostine Revenue Market Share by Company in 2019
Figure 22. Global Amifostine Sale Price by Company in 2019
Figure 23. Global Amifostine Consumption Market Share by Regions 2015-2020
Figure 24. Global Amifostine Value Market Share by Regions 2015-2020
Figure 25. Americas Amifostine Consumption 2015-2020 (MT)
Figure 26. Americas Amifostine Value 2015-2020 ($ Millions)
Figure 27. APAC Amifostine Consumption 2015-2020 (MT)
Figure 28. APAC Amifostine Value 2015-2020 ($ Millions)
Figure 29. Europe Amifostine Consumption 2015-2020 (MT)
Figure 30. Europe Amifostine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Amifostine Consumption 2015-2020 (MT)
Figure 32. Middle East & Africa Amifostine Value 2015-2020 ($ Millions)
Figure 33. Americas Amifostine Consumption Market Share by Countries in 2019
Figure 34. Americas Amifostine Value Market Share by Countries in 2019
Figure 35. Americas Amifostine Consumption Market Share by Type in 2019
Figure 36. Americas Amifostine Consumption Market Share by Application in 2019
Figure 37. United States Amifostine Consumption Growth 2015-2020 (MT)
Figure 38. United States Amifostine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Amifostine Consumption Growth 2015-2020 (MT)
Figure 40. Canada Amifostine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Amifostine Consumption Growth 2015-2020 (MT)
Figure 42. Mexico Amifostine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Amifostine Consumption Market Share by Countries in 2019
Figure 44. APAC Amifostine Value Market Share by Regions in 2019
Figure 45. APAC Amifostine Consumption Market Share by Type in 2019
Figure 46. APAC Amifostine Consumption Market Share by Application in 2019
Figure 47. China Amifostine Consumption Growth 2015-2020 (MT)
Figure 48. China Amifostine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Amifostine Consumption Growth 2015-2020 (MT)
Figure 50. Japan Amifostine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Amifostine Consumption Growth 2015-2020 (MT)
Figure 52. Korea Amifostine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Amifostine Consumption Growth 2015-2020 (MT)
Figure 54. Southeast Asia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 55. India Amifostine Consumption Growth 2015-2020 (MT)
Figure 56. India Amifostine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Amifostine Consumption Growth 2015-2020 (MT)
Figure 58. Australia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Amifostine Consumption Market Share by Countries in 2019
Figure 60. Europe Amifostine Value Market Share by Countries in 2019
Figure 61. Europe Amifostine Consumption Market Share by Type in 2019
Figure 62. Europe Amifostine Consumption Market Share by Application in 2019
Figure 63. Germany Amifostine Consumption Growth 2015-2020 (MT)
Figure 64. Germany Amifostine Value Growth 2015-2020 ($ Millions)
Figure 65. France Amifostine Consumption Growth 2015-2020 (MT)
Figure 66. France Amifostine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Amifostine Consumption Growth 2015-2020 (MT)
Figure 68. UK Amifostine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Amifostine Consumption Growth 2015-2020 (MT)
Figure 70. Italy Amifostine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Amifostine Consumption Growth 2015-2020 (MT)
Figure 72. Russia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 73. Spain Amifostine Consumption Growth 2015-2020 (MT)
Figure 74. Spain Amifostine Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Amifostine Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Amifostine Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Amifostine Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Amifostine Consumption Market Share by Application in 2019
Figure 79. Egypt Amifostine Consumption Growth 2015-2020 (MT)
Figure 80. Egypt Amifostine Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Amifostine Consumption Growth 2015-2020 (MT)
Figure 82. South Africa Amifostine Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Amifostine Consumption Growth 2015-2020 (MT)
Figure 84. Israel Amifostine Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Amifostine Consumption Growth 2015-2020 (MT)
Figure 86. Turkey Amifostine Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Amifostine Consumption Growth 2015-2020 (MT)
Figure 88. GCC Countries Amifostine Value Growth 2015-2020 ($ Millions)
Figure 89. Global Amifostine Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 90. Global Amifostine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Amifostine Consumption 2021-2025 (MT)
Figure 92. Americas Amifostine Value 2021-2025 ($ Millions)
Figure 93. APAC Amifostine Consumption 2021-2025 (MT)
Figure 94. APAC Amifostine Value 2021-2025 ($ Millions)
Figure 95. Europe Amifostine Consumption 2021-2025 (MT)
Figure 96. Europe Amifostine Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Amifostine Consumption 2021-2025 (MT)
Figure 98. Middle East & Africa Amifostine Value 2021-2025 ($ Millions)
Figure 99. United States Amifostine Consumption 2021-2025 (MT)
Figure 100. United States Amifostine Value 2021-2025 ($ Millions)
Figure 101. Canada Amifostine Consumption 2021-2025 (MT)
Figure 102. Canada Amifostine Value 2021-2025 ($ Millions)
Figure 103. Mexico Amifostine Consumption 2021-2025 (MT)
Figure 104. Mexico Amifostine Value 2021-2025 ($ Millions)
Figure 105. Brazil Amifostine Consumption 2021-2025 (MT)
Figure 106. Brazil Amifostine Value 2021-2025 ($ Millions)
Figure 107. China Amifostine Consumption 2021-2025 (MT)
Figure 108. China Amifostine Value 2021-2025 ($ Millions)
Figure 109. Japan Amifostine Consumption 2021-2025 (MT)
Figure 110. Japan Amifostine Value 2021-2025 ($ Millions)
Figure 111. Korea Amifostine Consumption 2021-2025 (MT)
Figure 112. Korea Amifostine Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Amifostine Consumption 2021-2025 (MT)
Figure 114. Southeast Asia Amifostine Value 2021-2025 ($ Millions)
Figure 115. India Amifostine Consumption 2021-2025 (MT)
Figure 116. India Amifostine Value 2021-2025 ($ Millions)
Figure 117. Australia Amifostine Consumption 2021-2025 (MT)
Figure 118. Australia Amifostine Value 2021-2025 ($ Millions)
Figure 119. Germany Amifostine Consumption 2021-2025 (MT)
Figure 120. Germany Amifostine Value 2021-2025 ($ Millions)
Figure 121. France Amifostine Consumption 2021-2025 (MT)
Figure 122. France Amifostine Value 2021-2025 ($ Millions)
Figure 123. UK Amifostine Consumption 2021-2025 (MT)
Figure 124. UK Amifostine Value 2021-2025 ($ Millions)
Figure 125. Italy Amifostine Consumption 2021-2025 (MT)
Figure 126. Italy Amifostine Value 2021-2025 ($ Millions)
Figure 127. Russia Amifostine Consumption 2021-2025 (MT)
Figure 128. Russia Amifostine Value 2021-2025 ($ Millions)
Figure 129. Spain Amifostine Consumption 2021-2025 (MT)
Figure 130. Spain Amifostine Value 2021-2025 ($ Millions)
Figure 131. Egypt Amifostine Consumption 2021-2025 (MT)
Figure 132. Egypt Amifostine Value 2021-2025 ($ Millions)
Figure 133. South Africa Amifostine Consumption 2021-2025 (MT)
Figure 134. South Africa Amifostine Value 2021-2025 ($ Millions)
Figure 135. Israel Amifostine Consumption 2021-2025 (MT)
Figure 136. Israel Amifostine Value 2021-2025 ($ Millions)
Figure 137. Turkey Amifostine Consumption 2021-2025 (MT)
Figure 138. Turkey Amifostine Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Amifostine Consumption 2021-2025 (MT)
Figure 140. GCC Countries Amifostine Value 2021-2025 ($ Millions)
Figure 141. Clinigen Amifostine Market Share (2018-2020)
Figure 142. Sun Pharmaceutical Amifostine Market Share (2018-2020)
Figure 143. Merro Pharmaceutical Amifostine Market Share (2018-2020)
Figure 144. Luye Pharma Amifostine Market Share (2018-2020)
Figure 145. Taj Pharmaceuticals Amifostine Market Share (2018-2020)
Figure 146. Mingren Pharma Amifostine Market Share (2018-2020)
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs